2-Amino-4-oxo-5-substituted-pyrrolo[2,3-d]pyrimidines as Nonclassical Antifolate Inhibitors of Thymidylate Synthase1a,b
- 1 January 1996
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 39 (23) , 4563-4568
- https://doi.org/10.1021/jm960097t
Abstract
Six novel 2-amino-4-oxo-5-[(substituted phenyl)sulfanyl]pyrrolo[2,3-d]pyrimidines 7−12 were synthesized as potential inhibitors of thymidylate synthase (TS) and as antitumor and/or antibacterial agents. The analogues contain a 5-thio substituent with a phenyl, 4‘-chlorophenyl, 3‘,4‘-dichlorophenyl, 4‘-nitrophenyl, 3‘,4‘-dimethoxyphenyl, and 2‘-naphthyl on the sulfur, and were synthesized from the key intermediate 2-(pivaloylamino)-4-oxo-6-methylpyrrolo[2,3-d]pyrimidine, 17. Appropriately substituted aryl thiols were appended to the 5-position of 17 via an oxidative addition reaction using iodine, ethanol, and water under conditions which also resulted in the deprotection of the 2-amino group. The compounds were evaluated against human, Lactobacillus casei, Escherichia coli, Streptococcus faecium, and Pneumocystis carinii (pc) TSs and against human, rat liver (rl), pc, and Toxoplasma gondii (tg) DHFRs. The nonclassical analogues with the 3‘,4‘-dichloro and the 4‘-nitro substituents in the side chain (9 and 10) were more potent than N-[4-[N-[(2-amino-3,4-dihydro-4-oxo-6-quinazolinyl)methyl]-N-prop-2-ynylamino]benzoyl]-l-glutamic acid (PDDF, 1) and N-[5-[N-[(3,4-dihydro-2-methyl-4-oxo-6-quinazolinyl)methyl]-N-methylamino]-2-thenoyl]-l-glutamic acid (ZD1694, 2) against human TS. Analogues with the 4‘-chloro, 3‘,4‘-dimethoxy, and naphthyl side chains (8, 11 and 12) were more potent than the unsubstituted phenyl analogue (7) but less than 2, 9, and 10 by 1 order of magnitude. They were all poor inhibitors of human, rl, and pc DHFRs (IC50 = 10-5 M) but moderate inhibitors (IC50 = 10-6 M) of tg DHFR. The 4-nitro analogue, 10 (EC50 1.5 μM), was comparable to PDDF in its potency as an inhibitor of the growth of the FaDu human squamous cell carcinoma cell line.Keywords
This publication has 13 references indexed in Scilit:
- THE CATALYTIC MECHANISM AND STRUCTURE OF THYMIDYLATE SYNTHASEAnnual Review of Biochemistry, 1995
- Biological activity of a novel rationally designed lipophilic thymidylate synthase inhibitorCancer Chemotherapy and Pharmacology, 1994
- Design of thymidylate synthase inhibitors using protein crystal structures: the synthesis and biological evaluation of a novel class of 5-substituted quinazolinonesJournal of Medicinal Chemistry, 1993
- A dideazatetrahydrofolate analog lacking a chiral center at C-6: N-[4-[2-(2-amino-3,4-dihydro-4-oxo-7H-pyrrolo[2,3-d]pyrimidin-5yl)ethyl[benzoyl]-L-glutamic acid is an inhibitor of thymidylate synthaseJournal of Medicinal Chemistry, 1992
- Crystal-structure-based design and synthesis of benz[cd]indole-containing inhibitors of thymidylate synthaseJournal of Medicinal Chemistry, 1992
- Design of enzyme inhibitors using iterative protein crystallographic analysisJournal of Medicinal Chemistry, 1991
- The renewed potential for folate antagonists in contemporary cancer chemotherapyJournal of Medicinal Chemistry, 1991
- The thymidylate synthesis cycle and anticancer drugsMedicinal Research Reviews, 1987
- A potent antitumour quinazoline inhibitor of thymidylate synthetase: Synthesis, biological properties and therapeutic results in micePublished by Elsevier ,1981
- The oxidation of thiols in the presence of pyrrolesAustralian Journal of Chemistry, 1971